Skip to content

November, 2010

November, 2010

Big Think hosted a panel discussion highlighting cutting-edge Alzheimer's disease research as part of our Breakthroughs series, made possible by Pfizer.

This conversation features back-and-forth exchanges between top luminaries in the field, including Dr. Samuel Gandy, Mount Sinai Professor of Alzheimer's Disease Research; Dr. Leonard Guarente, Director of Glenn Lab for Science of Aging at MIT; Dr. Juan Troncoso, Director of the Brain Resource Center at Johns Hopkins University School of Medicine; and Dr. Ottavio Arancio, Professor of Pathology & Cell Biology at the Columbia University Medical Center.  The panel was moderated by Meryl Comer, President of the Geoffrey Beene Foundation Alzheimer’s Initiative.

 


For much of the past 100 years, little was known about Alzheimer’s disease and dementia. But recent research is revealing the neurotransmitter and genetic defects behind the disease.
5 min
with